glp-1 agonists weight loss side effects Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for and Obesity adverse effects of glp-1 receptor

All components of the main kidney 5-composite endpoint were adjudicated by an independent expert committee blinded to treatment status

The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Obesity Treatment Over the past two years, the pharmaceutical industry has witnessed an unprecedented surge in the development and deployment of GLP-1 receptor agonists

[DOI] [PMC free article] [PubMed] [Google Scholar] 108.Richards J, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 332.Zhang X., Young R.L., Bound M., Hu S., Jones K.L., Horowitz M

Power, E

Eng J, Andrews PC, Kleinman WA, Singh L, and Raufman JP